Cibc Private Wealth Group, LLC Nautilus Biotechnology, Inc. Transaction History
Cibc Private Wealth Group, LLC
- $51.4 Billion
- Q2 2024
A detailed history of Cibc Private Wealth Group, LLC transactions in Nautilus Biotechnology, Inc. stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 200 shares of NAUT stock, worth $526. This represents 0.0% of its overall portfolio holdings.
Number of Shares
200
Previous 200
-0.0%
Holding current value
$526
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding NAUT
# of Institutions
82Shares Held
63.8MCall Options Held
2.9KPut Options Held
500-
Ah Equity Partners Bio Ii, L.L.C. Menlo Park, CA16.3MShares$42.9 Million24.08% of portfolio
-
Perceptive Advisors LLC New York, NY12.6MShares$33.1 Million0.85% of portfolio
-
Cercano Management LLC Bellevue, WA7.17MShares$18.9 Million0.45% of portfolio
-
Madrona Venture Group, LLC6.02MShares$15.8 Million15.03% of portfolio
-
Black Rock Inc. New York, NY3.83MShares$10.1 Million0.0% of portfolio
About Nautilus Biotechnology, Inc.
- Ticker NAUT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 124,663,000
- Market Cap $328M
- Description
- Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was found...